An official website of the United States government
Event Details
Description of Event
Virtual only.
2023-05-16T21:00:00Z 2023-05-16T14:00:00Z Videocast
7th Annual Vivian W. Pinn Symposium Videocast
Event Information
The Vivian W. Pinn Symposium honors the first full-time director of National Institutes of Health (NIH) Office of Research on Women's Health (ORWH), Dr. Vivian Pinn, and is held every year during National Women’s Health Week. This event serves as a critical forum for experts across sectors to communicate and collaborate for the advancement of women’s health.
The title of this year’s symposium is “Menopause and Optimizing Midlife Health of Women.” The symposium will discuss the menopausal transition, the accumulation of morbidity after menopause, menopause in special populations, the influence of social determinants of health on the experience of menopause, the use of menopausal hormonal therapy, and interventions to promote healthy aging.
Providing the keynote address, “Menopausal Hormone Therapy: 30 Years of Lessons from the Women’s Health Initiative,” is JoAnn Manson, M.D., M.P.H., Dr.P.H., MACP, Professor of Medicine and the Michael and Lee Bell Professor of Women's Health, Harvard Medical School, Chief of Preventive Medicine, Brigham and Women’s Hospital, Boston. A patient advocacy panel will discuss the patient perspective of menopause.
The objectives of the symposium are to:
- Familiarize attendees with the state of the science related to our understanding of risk factors and mechanisms that lead to reproductive aging.
- Understand women’s unique morbidity and multimorbidity burden to identify points of intervention.
- Identify the needs of populations at risk for iatrogenic menopause (e.g., patients with germline inherited cancer risk) and early or complex menopausal symptoms (e.g., patients living with HIV, chronic conditions, and cancer).
- Identify priorities to address the influence of environmental, social, and other exposures as they relate to menopausal transition and symptoms in diverse populations of women.
- Understand current recommendations on menopausal hormone therapy prescribing, including doses, formulations, and durations of use.
Agenda
Agenda
| 10:00–10:15 a.m.Videocast: 0:00 - 15:49 | Introduction | Sarah Temkin, M.D. Associate Director for Clinical Research, ORWHJanine Clayton, M.D., FARVO Director, ORWH |
| 10:15–10:50 a.m.Videocast: 15:49 - 59:35 | Opening Keynote: “Menopausal Hormone Therapy: 30 Years of Lessons from the Women’s Health Initiative” | JoAnn Manson, M.D., M.P.H., Dr.P.H., MACP Professor of Medicine and the Michael and Lee Bell Professor of Women’s Health, Harvard Medical School Chief of Preventive Medicine, Brigham and Women’s Hospital, Boston |
| 10:50–11:00 a.m.(Held after all speakers) | Q&A with Dr. Manson Moderator: Hadine Joffe, M.D., M.Sc. Paula A. Johnson Endowed Professor of Psychiatry in the Field of Women's Health, Harvard Medical School at Brigham and Women's Hospital | |
| 11:00–11:40 a.m. | Understanding the Menopausal Transition | |
| Videocast (Greendale) 59:40 - 1:22:34 | “The Menopause Transition: Definitions, Health Implications, Future Directions” | Gail Greendale, M.D. Professor of Medicine and Obstetrics and Gynecology, David Geffen School of Medicine at the University of California, Los Angeles |
| Videocast (Neal-Perry) 1:22:34 - 1:39:50 | “It’s Hot in Here! Understanding the Basic Biology of the Menopause Transition” | Genevieve Neal-Perry, M.D., Ph.D. Robert A. Ross Distinguished Professor and Chair, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill |
| 11:40 a.m.–12:20 p.m. | The Accumulation of Morbidity After Menopause | |
| Videocast (Rocca) 1:39:48 - 2:03:08 | “Premature or Early Menopause and Accelerated Accumulation of Multi-Morbidity” | Walter Rocca, M.D., M.P.H. Professor of Epidemiology and Neurology, Mayo Clinic College of Medicine and Science |
| Videocast (Kohrt) 2:03:02 - 2:23:57 | “To E or Not to E: Metabolic Actions of Estrogens” | Wendy Kohrt, Ph.D. Distinguished Professor of Medicine, Division of Geriatric Medicine, University of Colorado Anschutz Medical Campus |
| 12:20–12:35 p.m.Videocast Panel 2:24:32 - 2:46:06 | Panel Discussion, Q&A Moderator: Hadine Joffe, M.D., M.Sc. Paula A. Johnson Endowed Professor of Psychiatry in the Field of Women's Health, Harvard Medical School at Brigham and Women's Hospital | |
| 12:35–1:05 p.m. | Lunch Break | |
| 1:05–1:45 p.m. | Special Populations | |
| Videocast (Norquist) 2:51:30 - 3:12:35 | “Menopause and the High-Risk Patient” | Barbara S. Norquist, M.D. Associate Professor, Department of Obstetrics and Gynecology, University of Washington |
| Videocast (Lobby) 3:12:48 - 3:30:56 | “Menopause in Women with HIV: Emerging Knowledge & Special Considerations” | Sara Looby, Ph.D., ANP-BC, FAAN Assistant Professor of Medicine, Harvard Medical School |
| 1:45–2:25 p.m. | Social Determinants of Health | |
| Videocast (Harlow) 3:30:56 - 3:51:16 | “Social Determinants of Disparities in Menopause and Midlife Health: Considerations for Future Research” | Siobán D. Harlow, Ph.D. Professor Emerita of Epidemiology, Global Public Health, and Obstetrics and Gynecology, University of Michigan |
| Videocast (Cortes) 3:51:27 - 4:11:38 | "Un Cambio de Vida: Experiences and Social Determinants of Menopause Among Latinas" | Yamnia I. Cortés, Ph.D., M.P.H., FNP-BC, FAHA Assistant Professor, University of North Carolina at Chapel Hill School of Nursing |
| 2:25–2:45 p.m.Videocast: (Friedman) 4:11:38 - 4:26:38Videocast: (Baker) 4:26:40 - 4:38:04 | Patient Advocacy Perspective | Susan Friedman, D.V.M. Executive Director, Facing Our Risk of Cancer Empowered (FORCE)Dorcas Baker, RN, B.S.N., ACRN, M.A. Co-Founder, Older Women Embracing Life (OWEL) |
| 2:45–3:00 p.m.Videocast Panel/Q&A: 4:38:04 - 4:51:18 | Panel Discussion, Q&A Moderator: Rebecca Thurston, Ph.D., FABMR, FAPS Pittsburgh Foundation Chair in Women’s Health and Dementia, University of Pittsburgh | |
| 3:00–3:10 p.m. | Afternoon Break | |
| 3:10–3:50 p.m. | The Who, When, and What of Menopausal Hormone Therapy | |
| Videocast: (Miller) 4:51:31 - 5:14:14 | "The Science Behind Personalizing Hormone Treatments" | Virginia Miller, Ph.D., M.B.A. Professor Emerita of Surgery and Physiology, Mayo Clinic |
| Videocast: (Kaunitz) 5:14:14 - 5:35:25 | "Systemic Hormone Therapy for Symptom Management in Menopausal Women: Balancing Evidence with Clinical Judgement” | Andrew M. Kaunitz, M.D., FACOG, NCMP Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida |
| 3:50–4:30 p.m. | Interventions to Promote Healthy Aging | |
| Videocast: (LaCroix) 5:35:25 - 5:57:15 | “The Key Ingredients for Traversing a Healthy Menopause” | Andrea Z. LaCroix, Ph.D. Distinguished Professor of Epidemiology; Herbert Wertheim School of Public Health and Human Longevity Science; University of California, San Diego |
| Videocast: (Wild) 5:57:23 - 6:18:37 | “ORWH Research Agenda: Where We Are and Where We Need to Be” | Robert A. Wild, M.D., Ph.D., M.P.H. Professor of Obstetrics and Gynecology and Vice Chair for Research and Development, Department Obstetrics and Gynecology, Oklahoma University Health Sciences Center |
| 4:30–4:45 p.m.Videocast: Panel Discussion 6:18:37 - 6:25:28 | Panel Discussion, Q&A Moderator: Nanette Santoro, M.D. E. Stewart Taylor Chair of Obstetrics and Gynecology, University of Colorado School of Medicine | |
| 4:45–5:00 p.m.Videocast: Concluding Remarks 6:25:22 - 6:37:16 | Concluding Remarks | Vivian W. Pinn, M.D. Senior Scientist Emerita, Fogarty International Center, NIH Founding Director (Retired), ORWH |
Keynote Speaker
|
Image
| JoAnn Manson, M.D., M.P.H., Dr.P.H., MACP Professor of Medicine and the Michael and Lee Bell Professor of Women’s Health, Harvard Medical School Chief of Preventive Medicine, Brigham and Women’s Hospital, Boston |
America/New_York